| Henri C Tannas, MD | |
|
8210 Walnut Hill Ln Ste 408, Dallas, TX 75231-4428 | |
| (214) 647-1836 | |
| Not Available |
| Full Name | Henri C Tannas |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 22 Years |
| Location | 8210 Walnut Hill Ln Ste 408, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326235789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 233564 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Grapevine | Grapevine, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Two new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.
The Boston Globe reports on new federal government findings regarding a "crisis" in the New Hampshire state mental health system. Meanwhile, KHN reports on how mentally ill patients sometimes are left to languish in hospital emergency departments.
Diabetes affects roughly 30 million Americans, and is one of the leading causes of disability and mortality.
› Verified 7 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Two new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.
The Boston Globe reports on new federal government findings regarding a "crisis" in the New Hampshire state mental health system. Meanwhile, KHN reports on how mentally ill patients sometimes are left to languish in hospital emergency departments.
Diabetes affects roughly 30 million Americans, and is one of the leading causes of disability and mortality.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Henri C Tannas, MD 8210 Walnut Hill Ln Ste 408, Dallas, TX 75231-4428 Ph: (214) 647-1836 | Henri C Tannas, MD 8210 Walnut Hill Ln Ste 408, Dallas, TX 75231-4428 Ph: (214) 647-1836 |
News Archive
Two new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.
The Boston Globe reports on new federal government findings regarding a "crisis" in the New Hampshire state mental health system. Meanwhile, KHN reports on how mentally ill patients sometimes are left to languish in hospital emergency departments.
Diabetes affects roughly 30 million Americans, and is one of the leading causes of disability and mortality.
› Verified 7 days ago
Dr. Anthony Michael Tolisano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3102 | |
Presley M. Mock, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8440 Walnut Hill Ln, Ste 500, Dallas, TX 75231 Phone: 214-345-1491 Fax: 214-345-5708 | |
Dr. Jane Farrar Admire, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7777 Forest Ln, Suite C-100, Dallas, TX 75230 Phone: 972-566-4848 | |
Chung-en Huang, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3430 W Wheatland Rd Ste 209, Dallas, TX 75237 Phone: 972-780-1496 Fax: 972-709-1496 | |
Dr. Seckin Omer Ulualp, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-2905 | |
Dr. Kenneth H Lee, M.D., PH.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Ut Soutwestern Otolaryngology, Dallas, TX 45229 Phone: 214-648-2972 Fax: 214-648-9122 | |
Jacob Boston Hunter, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8898 Fax: 214-645-8894 |